+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GlaxoSmithKline PLC - logo

GlaxoSmithKline is a global healthcare company with a strong focus on applying their scientific expertise to provide a range of solutions to global challenges through designing innovative products for the treatment and relief of disease, developing vaccines to protect against infectious diseases and by promoting consumers active role in managing their health through the provision of over the counter products in areas such as skin care, oral health, pain relief and nutrition. Its product range includes such trusted brands as Stiefel Dermatology, Volteren, Panadol and Sensodyne.

From
From
Viral Vector Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Viral Vector Collaboration and Licensing Deals 2016-2026

  • Report
  • May 2026
  • 300 Pages
  • Global
From
Cardiotonic Agents Market - Global Strategic Business Report - Product Thumbnail Image

Cardiotonic Agents Market - Global Strategic Business Report

  • Report
  • August 2026
  • 568 Pages
  • Global
From
Long QT Syndrome Treatment - Global Strategic Business Report - Product Thumbnail Image

Long QT Syndrome Treatment - Global Strategic Business Report

  • Report
  • August 2026
  • 277 Pages
  • Global
From
Acute Coronary Syndrome - Global Strategic Business Report - Product Thumbnail Image

Acute Coronary Syndrome - Global Strategic Business Report

  • Report
  • August 2026
  • 494 Pages
  • Global
From
Calcium Channel Blockers - Global Strategic Business Report - Product Thumbnail Image

Calcium Channel Blockers - Global Strategic Business Report

  • Report
  • August 2026
  • 282 Pages
  • Global
From
Fondaparinux - Global Strategic Business Report - Product Thumbnail Image

Fondaparinux - Global Strategic Business Report

  • Report
  • August 2026
  • 180 Pages
  • Global
From
Dyslipidemia Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Dyslipidemia Drugs Market - Global Strategic Business Report

  • Report
  • August 2026
  • 268 Pages
  • Global
From
Atherosclerosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Atherosclerosis Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 181 Pages
  • Global
From
Lisinopril - Global Strategic Business Report - Product Thumbnail Image

Lisinopril - Global Strategic Business Report

  • Report
  • August 2026
  • 476 Pages
  • Global
From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 289 Pages
  • Global
From
Angina Pectoris Drugs - Global Strategic Business Report - Product Thumbnail Image

Angina Pectoris Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 241 Pages
  • Global
From
Heart Failure Drugs - Global Strategic Business Report - Product Thumbnail Image

Heart Failure Drugs - Global Strategic Business Report

  • Report
  • August 2026
  • 155 Pages
  • Global
From
Heparin - Global Strategic Business Report - Product Thumbnail Image

Heparin - Global Strategic Business Report

  • Report
  • August 2026
  • 546 Pages
  • Global
From
Loading Indicator